OpenPBTA: The Open Pediatric Brain Tumor Atlas is a dataset published in Cell Genomics (2023). On theSindex it has a DataRank of 1.3, placing it in the top 16.4% of the data-sharing corpus. It has been cited 62 times, with 39 citing works in its 1-hop citation network.
Ranks in the top 16% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.621
From this paper's citation signal
Citation Network Contribution
0.634
From 31 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 39 citers.
National Institutes of Health
Grant: 3P30 CA016520-44S5
Abramson Cancer Center Support Grant
National Institutes of Health
Grant: 75N91019D00024
National Institutes of Health
Grant: 75N91020F00003
National Institutes of Health
Grant: HHSN261200800001E
National Institutes of Health
Grant: K12GM081259
National Institutes of Health
Grant: R03-CA23036
National Institutes of Health
Grant: U24 CA220457-03
National Institutes of Health
Grant: U2C HL138346-03
National Institutes of Health
Grant: 3U2CHL138346-01S1
U2C Kids First Admin Supplement - data transfer
National Institutes of Health
Grant: 2P30CA016520-35
Abramson Cancer Center Support Grant
National Institutes of Health
Grant: 5K12GM081259-09
University of Pennsylvania Postdoctoral Opportunities in Research and Teaching
National Institutes of Health
Grant: 5U24CA220457-03
The cBioPortal for Cancer Genomics
NHLBI NIH HHS
Grant: U2C HL138346
NCI NIH HHS
Grant: U24 CA220457
NCI NIH HHS
Grant: P30 CA016520
NINDS NIH HHS
Grant: R01 NS119231
CCR NIH HHS
Grant: HHSN261200800001C
FWCI
11.17
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Additional file 5 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 3 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 4 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 1 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 2 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 3 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 1 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 5 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 4 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis
Additional file 2 of Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis